What is legal in Vietnam, and what Panya will route.
Bộ Y Tế (Ministry of Health) regulates medicines under the Pharmacy Law 105/2016/QH13 and subsequent amendments. Semaglutide (Ozempic, Wegovy, Rybelsus) is registered for Vietnamese prescription. Tirzepatide registration is still completing through 2025-2026, so brand Mounjaro stocking is meaningfully tighter than semaglutide and varies by international hospital pharmacy. Research peptides are not formally scheduled but are not approved for human use.
Three routes that stay on the right side of the line.
International hospital with imported brand product
FV Hospital (HCMC), Family Medical Practice (HCMC + Hanoi + Da Nang), Raffles Medical Vietnam, Vinmec International. English-fluent staff, English-language prescriptions formatted for international insurance. Cost runs USD 200 to 450 per month for the standard 5 to 10 mg semaglutide dose, consultation included. Tirzepatide stocking is intermittent through 2026 because Vietnamese registration is still completing; some hospital pharmacies hold imported Mounjaro from Singapore or Thailand routes, others source on demand.
Vietnamese pharmacy chain with prescription
Pharmacity, Long Châu, Phano. The major retail chains dispense Ozempic and (where stocked) Mounjaro against a Vietnamese or recognised international prescription. Vietnamese prescription rules are stricter at the pharmacy level than at the in-house clinic level — pharmacists actually check. Useful path if you have a Vietnamese GP or hospital prescription and want a familiar retailer with multiple locations.
Travel and use abroad
If you spend time in Thailand, the UAE, Singapore, or another country where Panya can route, the recommendation fits that country's rules. A legally purchased prescription medication brought back into Vietnam as a personal-use supply (typically up to 30 days) under the Vietnamese Customs personal-import allowance is generally tolerated when accompanied by a doctor's letter and original packaging. Larger quantities or repeated import patterns draw scrutiny, particularly via courier.
No Telegram resellers, no peptides without sterility QC.
Vietnam has a smaller research-chem channel market than Thailand, but the Telegram and Zalo resellers do exist. Bộ Y Tế has tightened enforcement against unlicensed pharmaceutical imports through 2024-2025; courier shipments without prescription documentation are increasingly held at customs. Panya does not route to those channels from any region. Research peptides (BPC-157, dihexa, the non-GLP-1 catalog at panya.health/peptide) are documented for transparency; we do not yet route to vendors for them anywhere.
Match you to an international-hospital prescriber.
Take the quiz from a Vietnam IP and you get matched against the 11-signal rubric to an international hospital or accredited expat clinic that scores 70/100 or higher. The match accounts for dose progression (Ozempic + Wegovy more consistently stocked than Mounjaro through 2026), city (HCMC, Hanoi, Da Nang availability differ), and whether you need an English-language prescription formatted for foreign insurance reimbursement. Where a vendor scores below the routable threshold we say so on the scorecard rather than skip-listing.
Where these rules live.
- Bộ Y Tế (Vietnam Ministry of Health): moh.gov.vn for the official medicines register and prescription-only classifications.
- Pharmacy Law 105/2016/QH13 and subsequent decrees: the framework for medicine scheduling, manufacturing authorisation, and pharmacy licensing in Vietnam.
- Vietnam General Department of Customs (Tổng cục Hải quan): medicine import rules for personal-use carry-on quantities versus declared imports.
- Vietnam Drug Administration (DAV) for prescription-only medicine register and pharmacy enforcement.
Regulation can change. This page was last reviewed April 2026. If you spot a rule we have wrong, email partner@panya.health and we will correct it the same week.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.